Literature DB >> 33389471

Restraint Stress Potentiated Morphine Sensitization: Involvement of Dopamine Receptors within the Nucleus Accumbens.

Elham Charmchi1, Golnaz Faramarzi1, Mina Rashvand2, Morteza Zendehdel1, Abbas Haghparast3.   

Abstract

Sensitization to psychostimulant drugs, as well as morphine, subjected to cross-sensitization with stress. The development of morphine sensitization is associated with enhancements in dopamine overflow in the Nucleus accumbens (NAc). This study aimed to examine the role of accumbal D1/D2-like dopamine receptors in restraint stress (RS) induced sensitization to morphine antinociceptive effects. Adult male Wistar rats weighing 220-250 g underwent stereotaxic surgery. Two stainless steel guide cannulae were bilaterally implanted, 1 mm above the NAc injection site. Different solutions of SCH-23390, as a D1-like receptor antagonist or sulpiride, as a D2-like receptor antagonist, were microinjected into the NAc five min before exposure to RS. Restraint stress lasted for 3 h, 10 min after RS termination; animals received a subcutaneous injection of morphine (1 mg/kg) for 3 consecutive days. The procedure was followed by a 5-day drug and/or stress-free period. After that, on the 9th day, the nociceptive response was evaluated by the tail-flick test. The results revealed that intra-NAc administration of D1/D2-like dopamine receptor antagonists, SCH-23390 or sulpiride, respectively, blocked morphine sensitization-induced by RS and morphine co-administration in rats for three consecutive days. This work provides new insight into the determinant role of accumbal dopamine receptors in morphine sensitization produced by RS-morphine co-administration.

Entities:  

Keywords:  D1-like dopamine receptor; D2-like dopamine receptor; Morphine; Nucleus accumbens; Rat; Sensitization; Stress; Tail-flick test

Year:  2021        PMID: 33389471     DOI: 10.1007/s11064-020-03199-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

Review 1.  Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.

Authors:  Gerald Zernig; Serge H Ahmed; Rudolf N Cardinal; Drake Morgan; Elio Acquas; Richard W Foltin; Paul Vezina; S Stevens Negus; Jose A Crespo; Petra Stöckl; Petra Grubinger; Ekkehard Madlung; Christian Haring; Martin Kurz; Alois Saria
Journal:  Pharmacology       Date:  2007-06-14       Impact factor: 2.547

2.  Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.

Authors:  Zahra Reisi; Mahtash Bani-Ardalan; Leila Zarepour; Abbas Haghparast
Journal:  Pharmacol Biochem Behav       Date:  2014-01-10       Impact factor: 3.533

3.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 4.  Behavior genetics of drug sensitization.

Authors:  T J Phillips
Journal:  Crit Rev Neurobiol       Date:  1997

Review 5.  Dopamine and drug addiction: the nucleus accumbens shell connection.

Authors:  Gaetano Di Chiara; Valentina Bassareo; Sandro Fenu; Maria Antonietta De Luca; Liliana Spina; Cristina Cadoni; Elio Acquas; Ezio Carboni; Valentina Valentini; Daniele Lecca
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

6.  Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.

Authors:  Dan P Covey; Kendra D Bunner; Douglas R Schuweiler; Joseph F Cheer; Paul A Garris
Journal:  Eur J Neurosci       Date:  2016-05-11       Impact factor: 3.386

Review 7.  Conditioned cues and the expression of stimulant sensitization in animals and humans.

Authors:  Paul Vezina; Marco Leyton
Journal:  Neuropharmacology       Date:  2008-07-09       Impact factor: 5.250

8.  Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation.

Authors:  G H Tjon; T J De Vries; E Ronken; F Hogenboom; G Wardeh; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1994-02-03       Impact factor: 4.432

9.  Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.

Authors:  Yang Lv; Rong-Rong Hu; Manyi Jing; Tai-Yun Zhao; Ning Wu; Rui Song; Jin Li; Gang Hu
Journal:  Acta Pharmacol Sin       Date:  2018-09-17       Impact factor: 6.150

10.  Melatonin regulation of transcription in the reversal of morphine tolerance: Microarray analysis of differential gene expression.

Authors:  Yu-Che Cheng; Ru-Yin Tsai; Yen-Tseng Sung; Ing-Jung Chen; Tzu-Yi Tu; Ya-Yuan Mao; Chih-Shung Wong
Journal:  Int J Mol Med       Date:  2018-12-18       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.